Copyright ©The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Virology. Feb 12, 2015; 4(1): 25-32
Published online Feb 12, 2015. doi: 10.5501/wjv.v4.i1.25
Current molecular methods for the detection of hepatitis C virus in high risk group population: A systematic review
Rushna Firdaus, Kallol Saha, Aritra Biswas, Provash Chandra Sadhukhan
Rushna Firdaus, Kallol Saha, Aritra Biswas, Provash Chandra Sadhukhan, ICMR Virus Unit, I.D and B.G Hospital Campus, GB-4 (East Wing), Beliaghata, Kolkata 700010, India
Author contributions: Firdaus R and Saha K contributed equally to the work, wrote the manuscript and prepared the figures; Biswas A helped them and Sadhukhan PC looked into overall aspect in manuscript study design and checked the draft.
Conflict-of-interest: The authors have no conflict of interest to report
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See:
Correspondence to: Dr. Provash Chandra Sadhukhan, I.C.M.R. Virus Unit Kolkata, I.D and B.G Hospital Campus, GB-4 (East Wing), 1st Floor, 57, Dr. Suresh Chandra Banerjee Road, Beliaghata, Kolkata 700010, India.
Telephone: +91-33-23537425 Fax: +91-33-23537424
Received: September 24, 2014
Peer-review started: September 26, 2014
First decision: October 28, 2014
Revised: December 13, 2014
Accepted: December 29, 2014
Article in press: December 31, 2014
Published online: February 12, 2015
Core Tip

Core tip: The review focuses on the current molecular diagnostic techniques that are being used to detect hepatitis C virus worldwide. Special emphasis is given on the detection techniques that can be used to screen the individuals with repeated blood transfusion history; particularly thalassaemic individuals, intravenous drug users and persons on hemodialysis.